← Back to Search

1% YP-P10 Ophthalmic Solution for Dry Eye Syndrome

Phase 2
Waitlist Available
Research Sponsored by Yuyu Pharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 85
Awards & highlights

Summary

This trial is testing YP-P10 eye drops to see if they can help people with dry eyes. The study will compare two different strengths of the eye drops. The goal is to see if these drops can reduce discomfort and improve the health of the eye surface. Thymosin β4 has shown potential as an effective therapeutic for dry eye.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 85
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 85 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ocular Discomfort Score
Total Corneal Fluorescein Staining
Secondary study objectives
Adverse Event Query - Non Ocular TEAEs
Adverse Event Query - Ocular TEAEs
Adverse Event Query - SEA Reported
+34 more

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: 1% YP-P10 Ophthalmic SolutionActive Control1 Intervention
Group II: 0.3% YP-P10 Ophthalmic SolutionActive Control1 Intervention
Group III: YP-P10 Placebo Ophthalmic Solution (vehicle)Placebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Yuyu Pharma, Inc.Lead Sponsor
7 Previous Clinical Trials
528 Total Patients Enrolled
~81 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top